Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
悦耳碧萱发布了新的文献求助30
2秒前
科研通AI6.2应助蕊蕊采纳,获得10
4秒前
小二郎应助小夏饭桶采纳,获得10
4秒前
6秒前
Kairos_Duan发布了新的文献求助10
6秒前
何曼慈发布了新的文献求助10
7秒前
wan发布了新的文献求助10
10秒前
10秒前
yy完成签到,获得积分10
12秒前
东郭乾完成签到 ,获得积分10
13秒前
13秒前
苗条的凝芙完成签到,获得积分10
14秒前
JacobDu666完成签到,获得积分10
16秒前
康敏完成签到,获得积分20
17秒前
潇洒的绮山完成签到,获得积分10
17秒前
花再完成签到,获得积分10
18秒前
19秒前
19秒前
小二郎应助科研小王采纳,获得10
20秒前
秋风细细雨完成签到,获得积分10
20秒前
xiaoxinbaba发布了新的文献求助10
20秒前
nono发布了新的文献求助10
21秒前
22秒前
今后应助辛勤的乌采纳,获得10
23秒前
24秒前
面包学习发布了新的文献求助10
25秒前
YF_1987发布了新的文献求助10
26秒前
26秒前
li完成签到,获得积分10
28秒前
小二郎应助Pzmmm采纳,获得10
30秒前
桐桐应助史萌采纳,获得10
30秒前
Orange应助miaomiao采纳,获得10
30秒前
高大剑通应助dqbhxwx采纳,获得10
31秒前
笑尽往事完成签到,获得积分10
31秒前
小杜完成签到,获得积分10
31秒前
ccc12306发布了新的文献求助10
32秒前
球球尧伞耳完成签到,获得积分10
32秒前
chen132422完成签到,获得积分10
33秒前
爆米花应助文浩采纳,获得10
33秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Inorganic Chemistry Eighth Edition 1200
Free parameter models in liquid scintillation counting 1000
Anionic polymerization of acenaphthylene: identification of impurity species formed as by-products 1000
Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens, 7th edition 1000
HANDBOOK OF CHEMISTRY AND PHYSICS 106th edition 1000
ASPEN Adult Nutrition Support Core Curriculum, Fourth Edition 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6312690
求助须知:如何正确求助?哪些是违规求助? 8129194
关于积分的说明 17035065
捐赠科研通 5369605
什么是DOI,文献DOI怎么找? 2850915
邀请新用户注册赠送积分活动 1828714
关于科研通互助平台的介绍 1680949